Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J OSBORNE

Showing results (641-650 of 664) with videos related to

Pageof 67
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart RateEmmanuel H Demont, Benjamin I Andrews, Rino A Bit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2018
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 GlomerulopathyAmy J Osborne, Matteo Breno, Nicolo Ghiringhelli Borsa, et al.
Archives of Toxicology|September 9, 2025
Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologiesAngela Bearth, Birgit Kopainsky, Lowenna B Jones, et al.
British Journal of Haematology|August 14, 2009
A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosisClare C Constantine, Greg J Anderson, Chris D Vulpe, et al.
Science Advances|March 27, 2021
Predicting the severity of the grass pollen season and the effect of climate change in Northwest EuropeAlexander Kurganskiy, Simon Creer, Natasha de Vere, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Journal of Medicinal Chemistry|January 12, 2016
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral DosesEmmanuel H Demont, James M Bailey, Rino A Bit, et al.
Vaccine|February 2, 2026
SARS-CoV-2T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trialCamilla Tøndel, Synne Jenum, Kristian Tonby, et al.
JCO Clinical Cancer Informatics|August 15, 2025
Development of a Machine Learning Model for Aspyre Lung Blood: A New Assay for Rapid Detection of Actionable Variants From Plasma in Patients With Non-Small Cell Lung CancerRebecca N Palmer, Sam Abujudeh, Magdalena Stolarek-Januszkiewicz, et al.
Frontiers in Oncology|October 10, 2024
ASPYRE-Lung: validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissueRyan T Evans, Elizabeth Gillon-Zhang, Julia N Brown, et al.
Pageof 67

Showing results (641-650 of 664) with videos related to

Sort By:
Pageof 67
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart RateEmmanuel H Demont, Benjamin I Andrews, Rino A Bit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2018
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 GlomerulopathyAmy J Osborne, Matteo Breno, Nicolo Ghiringhelli Borsa, et al.
Archives of Toxicology|September 9, 2025
Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologiesAngela Bearth, Birgit Kopainsky, Lowenna B Jones, et al.
British Journal of Haematology|August 14, 2009
A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosisClare C Constantine, Greg J Anderson, Chris D Vulpe, et al.
Science Advances|March 27, 2021
Predicting the severity of the grass pollen season and the effect of climate change in Northwest EuropeAlexander Kurganskiy, Simon Creer, Natasha de Vere, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Journal of Medicinal Chemistry|January 12, 2016
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral DosesEmmanuel H Demont, James M Bailey, Rino A Bit, et al.
Vaccine|February 2, 2026
SARS-CoV-2T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trialCamilla Tøndel, Synne Jenum, Kristian Tonby, et al.
JCO Clinical Cancer Informatics|August 15, 2025
Development of a Machine Learning Model for Aspyre Lung Blood: A New Assay for Rapid Detection of Actionable Variants From Plasma in Patients With Non-Small Cell Lung CancerRebecca N Palmer, Sam Abujudeh, Magdalena Stolarek-Januszkiewicz, et al.
Frontiers in Oncology|October 10, 2024
ASPYRE-Lung: validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissueRyan T Evans, Elizabeth Gillon-Zhang, Julia N Brown, et al.
Pageof 67